Pfizer Inc. (NYSE:PFE) is included among Dividend Contenders List: Top 20 Stocks. Reuters reported on January 20 that Britain ...

Novavax’s Pfizer Matrix-M licensing deal brings $30M upfront, milestones & royalties. Read the full analysis here.

Pfizer is rated a buy due to its robust drug pipeline, focus on improving financials, and significant long-term growth potential despite near-term headwinds. PFE delivered strong results in H1, with ...

Albert Bourla said Pfizer has discussed a fast-pass voucher with the White House during the JPMorgan Healthcare Conference.

The healthcare giant has had trouble winning over investors in the past year despite an incredibly low valuation.

The anti-obesity drug market has the potential to be massive, with multiple analysts projecting it may reach at least $100 billion by 2030. As a result, many top healthcare companies are vying for a ...

Pfizer’s stake in ViiV Healthcare will be taken over by Shiongi, another minority shareholder in the HIV medicines company.

Pfizer's stock has started to turn higher, but it is still down massively; is now the time to jump aboard?

The appointment of Boshoff as head of R&D also comes as Pfizer fends off activist investor Starboard Value, which has accused the company of running poor research and development operations, and of ...

Both Ford and Pfizer have very attractive dividend yields.

Biopharmaceutical giant Pfizer has offered AU$100 million (US$74.43 million) to acquire Australian company ResApp, which has developed a mobile app to diagnose COVID-19 by the sound of a person's ...

COVID-19 had a dramatic impact on Rockland. The county was one of the first and one of the worst sites for cases in spring 2020. Since the pandemic hit New York, the Rockland County Medical Examiner ...